Return to Search Results
Print

Purpose

The purpose of the study is to evaluate the safety and tolerability of a 30-week aerobic exercise therapy program in cancer patients recovering from COVID-19. The study will look at whether the aerobic exercise therapy causes few or mild side effects in participants. Aerobic exercise is physical activity that uses the large muscle groups (muscles in your legs, buttocks, back, and chest) and can be performed for several minutes at a time. The aerobic exercise therapy being used in this study will be a walking program that will be adjusted so it matches participant fitness levels (how much exercise you can handle).

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 18 - Previously admitted to a hospital for Covid-19 - Discharged from hospital for at least 30 days - Previously treated for cancer at MSK - Interval of ≥ 12 months but ≤ 10 years following completion of primary non-hormonal anti-cancer therapy (current endocrine therapy and maintenance therapy allowed) - Space to house a treadmill at personal residence - Cleared for exercise participation as per screening clearance via the Physical Activity Readiness Questionnaire (PAR-Q+) - Performing less than 90 minutes of structured moderate-intensity or strenuous-intensity exercise per week, as evaluation by self-report - If a female of child-bearing potential, must not be pregnant or planning to become pregnant during the study. - Women <50 years old who are of child-bearing potential must have a negative pregnancy test within 14 days of enrollment.

Exclusion Criteria

  • Currently receiving home oxygen after discharge - Enrollment onto any other interventional investigational study - Current treatment for any other diagnosis of invasive cancer of any kind - Distant metastatic malignancy of any kind - Receiving non-hormonal anticancer therapy - Any other condition or intercurrent illness that, in the opinion of the investigator, makes the subject a poor candidate for study participation

Study Design

Phase
Phase 1
Study Type
Interventional
Allocation
N/A
Intervention Model
Single Group Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Participants who were hospitalized for COVID-19 		Participants will be post-cancer treatment patients who were hospitalized for COVID-19.
  • Other: Aerobic Exercise Therapy
    Aerobic Exercise Therapy/AT will consist of 30 weeks of treadmill walking sessions. AT will consist of supervised, individualized walking delivered up to 6 times weekly (over a 7-day period) to achieve a cumulative total duration ranging from 90 mins/wk up to 375 mins/wk following a non-linear dosing schedule. The planned dose and scheduling of AT will be continually altered and progressed in conjunction with appropriate rest/recovery sessions across the entire intervention period (i.e., non-linear periodized schedule).
    Other names:
    • AT

Recruiting Locations

More Details

NCT ID
NCT04824443
Status
Active, not recruiting
Sponsor
Memorial Sloan Kettering Cancer Center

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.